Document Detail


Surgical and percutaneous myocardial angiogenesis induction. Part II--neoangiogenesis.
MedLine Citation:
PMID:  11214697     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
Coronary artery bypass surgery and angioplasty provide symptomatic relief in patients with ischemic heart disease, but despite advancement in technique and devices, these methods are not applicable to a subset of patients with angina refractory to medical treatment. Bypass surgery might not be feasible because of lack of suitable conduits, diffuse coronary disease or poor distal run-off, and coronary angioplasty is sometimes not applicable due to chronic total occlusion, diffuse disease or extreme tortuosity. We have previously reviewed the available experience with laser-induced direct myocardial revascularization, one of the new potential treatment modalities for this patient subset. One of the potential mechanisms of action for laser treatment is the induction of neoangiogenesis. In the second part of our article we review the available experience with the induction of myocardial angiogenesis using different growth factors or the genes encoding for them.
Authors:
G Gimelli; C Di Mario; F Liistro; A V Dharmadhikari; M Montorfano; A Anzuini; M Vaghetti; M Puchala-Borowik; F Airoldi; M Carlino; V Tzifos; F Maisano; O Alfieri; A Colombo
Related Documents :
1563867 - Total recovery of left ventricular function after acute myocardial infarction: comprehe...
2973377 - Percutaneous transluminal coronary angioplasty improves survival in acute myocardial in...
8279347 - Effects of coronary angioplasty on left ventricular function.
2957057 - Value of immediate coronary angioplasty following intracoronary thrombolysis in acute m...
17380307 - Resident cardiac stem cells.
2765327 - Postpartum myocardial infarction.
Publication Detail:
Type:  Journal Article; Review    
Journal Detail:
Title:  Italian heart journal : official journal of the Italian Federation of Cardiology     Volume:  2     ISSN:  1129-471X     ISO Abbreviation:  Ital Heart J     Publication Date:  2001 Jan 
Date Detail:
Created Date:  2001-02-14     Completed Date:  2001-06-07     Revised Date:  2005-11-16    
Medline Journal Info:
Nlm Unique ID:  100909716     Medline TA:  Ital Heart J     Country:  Italy    
Other Details:
Languages:  eng     Pagination:  21-4     Citation Subset:  IM    
Affiliation:
Department of Interventional Cardiology, Columbus Hospital, Milan, Italy.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Coronary Disease / drug therapy*,  physiopathology
Disease Models, Animal
Endothelial Growth Factors / physiology,  therapeutic use*
Fibroblast Growth Factors / physiology
Gene Therapy / methods
Humans
Lymphokines / therapeutic use
Neovascularization, Physiologic / physiology*
Vascular Endothelial Growth Factor A
Vascular Endothelial Growth Factors
Chemical
Reg. No./Substance:
0/Endothelial Growth Factors; 0/Lymphokines; 0/Vascular Endothelial Growth Factor A; 0/Vascular Endothelial Growth Factors; 62031-54-3/Fibroblast Growth Factors

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Echo-Doppler evaluation of left ventricular diastolic dysfunction during acute myocardial infarction...
Next Document:  Spinal cord stimulation in patients with refractory anginal pain and normal coronary arteries.